Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Gains from Sales and Divestitures (2017 - 2022)

Usana Health Sciences has reported Gains from Sales and Divestitures over the past 6 years, most recently at $3000.0 for Q1 2022.

  • Quarterly Gains from Sales and Divestitures fell 97.12% to $3000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Jan 2022, down 97.12% year-over-year, with the annual reading at $3000.0 for FY2022, 97.12% down from the prior year.
  • Gains from Sales and Divestitures was $3000.0 for Q1 2022 at Usana Health Sciences, down from $104000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $104000.0 in Q1 2021 and troughed at $3000.0 in Q4 2018.
  • The 4-year median for Gains from Sales and Divestitures is $31000.0 (2018), against an average of $42250.0.
  • Year-over-year, Gains from Sales and Divestitures surged 1866.67% in 2019 and then tumbled 97.12% in 2022.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $3000.0 in 2018, then surged by 1866.67% to $59000.0 in 2019, then soared by 76.27% to $104000.0 in 2021, then tumbled by 97.12% to $3000.0 in 2022.
  • Per Business Quant, the three most recent readings for USNA's Gains from Sales and Divestitures are $3000.0 (Q1 2022), $104000.0 (Q1 2021), and $59000.0 (Q4 2019).